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Do Archaea and bacteria co-infection have a role in the pathogenesis 
of chronic chagasic cardiopathy?
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Chronic cardiopathy (CC) in Chagas disease is a fibrotic myocarditis with C5b-9 complement deposition. My-
coplasma and Chlamydia may interfere with the complement response. Proteolytic enzymes and archaeal genes that 
have been described in Trypanosoma cruzi may increase its virulence. Here we tested the hypothesis that different 
ratios of Mycoplasma, Chlamydia and archaeal organisms, which are frequent symbionts, may be associated with 
chagasic clinical forms. Materials and methods: eight indeterminate form (IF) and 20 CC chagasic endomyocardial 
biopsies were submitted to in situ hybridization, electron and immunoelectron microscopy and PCR techniques for 
detection of Mycoplasma pneumoniae (MP), Chlamydia pneumoniae (CP), C5b-9 and archaeal-like bodies. Results: 
MP and CP-DNA were always present at lower levels in CC than in IF (p < 0.001) and were correlated with each 
other only in CC. Electron microscopy revealed Mycoplasma, Chlamydia and two types of archaeal-like bodies. 
One had electron dense lipid content (EDL) and was mainly present in IF. The other had electron lucent content 
(ELC) and was mainly present in CC. In this group, ELC correlated negatively with the other microbes and EDL and 
positively with C5b-9. The CC group was positive for Archaea and T. cruzi DNA. In conclusion, different amounts 
of Mycoplasma, Chlamydia and archaeal organisms may be implicated in complement activation and may have a 
role in Chagas disease outcome.
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Chagas heart disease is described as a cardiomyopa-
thy secondary to Trypanosoma cruzi infection. Antigens 
(Higuchi et al. 1993a, Bellotti et al. 1996, 1998) and DNA 
(Jones et al. 1993) from T. cruzi are found within the 
inflammatory infiltrate of the myocardium. The scarce 
amount of parasite product present is associated with 
an intense inflammatory infiltrate suggesting alterna-
tive mechanisms of pathogenesis (Higuchi et al. 2003a, 
Marin-Neto et al. 2007). One proposed theory is that 
the parasite releases polyclonal activators, which would 
favour the development of autoimmune injury (Gao et 
al. 2003). Alternatively, the presence of the parasite may 
alter myosin in such away that it would be recognized 
as non-self myosin by lymphocytes (Cunha-Neto et al. 
1995). One theory not yet explored is the possible con-
comitance of additional infectious agents with T. cruzi.
Interactions between agents and co-infections have 
been reported in experimental studies with T. cruzi and 
in clinical reports of myocarditis (Andreoli et al. 2006, 
Cortez et al. 2006, Chimenti et al. 2007, Walder et al. 
2007) and non-myocardial diseases. Mycoplasma and 
Chlamydia are frequent symbionts (Horn & Wagner 
2004) and Mycoplasma in the cytoplasm of Trichomo-
nas causes chronic resistant genital infection (Dessi et 
al. 2005). Biofilms may be involved in development of 
plaque vulnerability (Katz & Shannon 2006). We have 
frequently found Mycoplasma pneumoniae and Chla-
mydia pneumoniae antigens in the coronary arteries 
and valves of normal hearts and in increased amounts 
in hearts affected by chronic inflammatory disorders 
involving stenotic aortic valves (Higuchi et al. 2002) and 
ruptured atherosclerotic plaques (Higuchi et al. 2000, 
2003b). We observed that the intimal association between 
Mycoplasma and Chlamydia occurred in the presence of 
archaeal-like forms associated with myxoid matrix in 
vulnerable plaques (Higuchi et al. 2006b).
Archaea, one of the three domains of life, is a highly 
diverse and abundant group of prokaryotes and includes 
a number of “extremophiles” that thrive in such environ-
ments as hot springs, salt lakes and submarine volcanic 
habitats (Madigan et al. 2000). Recent molecular studies 
have also revealed that archaea, like bacteria, are com-
monly mesophilic (DeLong 1992).
Multiple archaeal genomes have been sequenced 
and a large number of Archaeal-like genes have been 
described in persistent pathogens. It has been suggested 
that archaeal genes may confer metabolic capabilities 
as adaptive strategies for survival, even in hostile host 
niches, by allowing them to breach host barriers that ex-
clude other organisms (Srinivasan & Morowitz 2006). 
This effort has contributed to a better understanding 
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of archaeal cellular processes. Some archaeal charac-
teristics, such as M32 metallo carboxypeptidase (MCP) 
and two types of proteasome similar to those found in a 
common archaeal-eubacterial ancestor, were described 
in T. cruzi (Niemirowicz et al. 2007, Gille et al. 2003). 
A microbial consortium between a bacterium and a 
phylogenetically, distantly related archaeon has been 
suggested to promote the growth of both microbes in 
freshwater and marine sediments (Boetius et al. 2000, 
Raghoebarsing et al. 2006).
However, over half of the archaeal genes encode 
unique proteins of unknown function and no defini-
tive virulence genes or factors have been described in 
archaea to date. Archaea share access to their host and 
are capable of long-term colonization and coexistence 
with endogenous flora in the host. The detection of an-
aerobic archaea among the human colonic (Miller et al. 
1982, Miller & Wolin 1983), vaginal (Belay et al. 1990) 
and oral microbial flora (Belay et al. 1988) demonstrates 
their ability to colonize the human host. Details regard-
ing their survival in such human niches, including their 
ability to evade the human immune system and compete 
with normal human flora, however, are practically un-
available (Eckburg et al. 2003).
Lepp et al. (2004) established correlations between 
the presence of disease and the presence of archaeal 
DNA, the severity of periodontal disease and the relative 
abundance of archaeal DNA in subgingival plaque, and 
between disease resolution and diminished archaeal DNA 
abundance. Archaeal genomes contain partial tad loci, 
which may encode Tad-like proteins involved in fibril 
formation and surface adherence (Lepp et al. 2004).
The complement system is a major component of in-
nate immunity and provides an effective host defence 
mechanism against pathogens (Muller-Eberhard 1988). 
Mycoplasma may cause chronic disease in part by 
evading the immune response through antigenic varia-
tion and resistance to complement lysis (Simmons et al. 
2004). The terminal complement complex C5b-9 was 
detected in the myocardium of chronic cardiac (CC) 
chagasic patients (Aiello et al. 2002). C5b-9 participates 
in several inflammatory and proliferative processes by 
releasing pro-inflammatory cytokines and growth fac-
tors from target cells. Sublytical doses of C5b-9 may 
promote cell proliferation (Niculescu et al. 1999, Hal- 
perin 1993) and participate in the development of severe 
fibrosis in chagasic cardiomyopathy.
We hypothesized that a consortium involving bac-
teria, archaea and T. cruzi might be related to different 
chronic chagasic disease outcomes, including CC and 
indeterminate asymptomatic form (IF). CC is associ-
ated with increased complement activation, fibrosis 
and lymphocytic myocarditis. IF is associated with the 
presence of Mycoplasma and Chlamydia, which leads 
to decreased complement activation and degradation of 
myosin, preventing an “auto-immune” reaction.
In the present work we investigated whether en-
domyocardial biopsies of CC or IF chagasic patients 
present forms and antigens or DNA from M. pneumo-
niae, C. pneumoniae or archaeal organisms, and whether 
they are associated with each other and with C5b-9.
MATERIALS AND METHODS
This work was approved by the Ethical and Scientific 
Committee of Heart Institute, University of São Paulo, 
Shool of Medicine, São Paulo, Brazil. We reviewed 
endomyocardial biopsies from chagasic patients with 
indeterminate or chronic cardiac forms, performed 
between 1980-2001 at the Heart Institute of São Paulo. 
We compared the amount of M. pneumoniae DNA (MP-
DNA), M. pneumoniae DNA (CP-DNA) and archaeal-
like bodies in myocardial fragments of chagasic patients 
with the IF versus CC form using in situ hybridization 
(ISH), immunoelectron microscopy, electron microscopy 
and PCR. As the fragments were too small, we could 
not use the same case for multiple techniques. Therefore, 
correlations between the results obtained with different 
techniques were not determined in this study. Archaea-
like bodies were quantified according to their morphol-
ogy by electron microscopy since we do not have spe-
cific antibodies or probes. DNA from CC fragments was 
amplified with specific primers for the Archaea domain.
ISH analysis - in situ myocardial detection of MP-
DNA and CP-DNA by light microscopy - Serial sections 
of paraffin embedded endomyocardial biopsy fragments 
from 24 patients with Chagas disease were submitted to 
ISH for identification of MP-DNA and CP-DNA. Of the 
24 fragments, seven were of indeterminate form (men 
age 34 ± 11 years, 3 males), and 17 were associated with 
heart failure (37 ± 12 years, 11 males).
Cell permeabilization was achieved using a 0.01 M 
citrate buffered solution, pH 6.0  ± 0.1, in the microwave 
oven following the protocol for heat-induced target re-
trieval described for IHC. Endogenous peroxidase was 
blocked with H2O2 at 3% for 20 min at 37
o C. Tissue pro-
teins were blocked with serum free protein block (Dako, 
Carpinteria, CA, USA) for 15 min at 37oC. Next, 20 µL 
of hybridization mixture containing the probe, deionized 
formamide, 50% dextran sulfate, 20X SSC, Denhardt so-
lution, salmon sperm DNA, yeast tRNA, poly A and poly 
C, and diethyl pyrocarbonate pure water, was applied to 
the sections and overlaid with a coverslip. The M. pneu-
moniae probe was prepared from a highly specific M. 
pneumoniae clone (Enzo Diagnosis, Farmingdale, NY, 
USA). The biotin-labelled M. pneumoniae oligonucle-
otide probe was synthesized by GIBCO/BRL (Rock-
ville, MD, USA). The target DNA double-strands were 
denatured at 95 ± 5oC for 6 min. DNA hybridization was 
performed for 18 h in a humidity chamber at 37oC. After 
hybridization, the coverslip was removed with 0.0 5M 
Tris/HCl and 0.003 mM NaCl, pH 7.6, containing 0.1% 
Tween 20. Non-specific hybrids were excluded with post 
hybridization washes in 0.2x SSC for 10 min at 50oC 
and 2x SSC for 10 min at 37oC. The signal was ampli-
fied using the Catalyzed Signal Amplification system 
(Dako, Carpinteria, CA, USA). The reaction was visu-
alized with chromogen 3,3-diaminobenzidine (Dako, 
Carpinteria, CA, USA) for 5 min at RT. Sections were 
counterstained with Harris’ haematoxylin and mounted 
with Entellan resin (Merck, Darmstadt, Germany). Con-
trols: negative controls were carried out by omitting the 
probe or the primary antibody. As a positive control for 
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all reactions, we used human tissue sections known to be 
positive for M. pneumoniae and C. pneumoniae. In ad-
dition, as a positive control for ISH, we used a repetitive 
Alu sequence probe (alu1/alu2) by Genetic Research (Al, 
USA) and for negative control we used a plasmid DNA 
labelled with biotin (Dako, Carpinteria, CA, USA).
The positive brown dots that represent DNA of M. 
pneumoniae and C. pneumoniae were detected by an im-
age analysis system (Quantimet-500 Leica) and the mean 
percentage area for each DNA in all EMB was obtained.
Electron microscopy quantification of archaea by 
ultrastructural morphology and M. pneumoniae and 
C. pneumoniae by immune staining - Araldite embed-
ded endomyocardial fragments collected between 1980-
1986 from five patients with the IF and five with the CC 
form were submitted to semi-thin and thin sectioning 
and were examined by electron microscopy.
Morphological analysis - The material was photo-
graphed at a magnification of 2600X, allowing clear vi-
sualization of the myocardial fibre alterations and count-
ing of the archaeal-like bodies.
Immunoelectron microscopy - Immunogold labelling 
was performed for detection of M. pneumoniae, C. pneu-
moniae and C5b-9 from nine biopsy fragments. Of these, 
five were from patients with indeterminate form (2 males 
and 3 females, mean age 33 ± 13 years) and four were 
from patients with chronic Chagas disease with heart 
failure (3 males and 1 female, mean age 38 ± 22 years).
Ultrathin sections were submitted to immunogold 
electron microscopy after etching with 12.5% ultrafil-
tered sodium metaperiodate. The slices were incubated 
with primary antibodies for 20 h. The primary antibod-
ies use were monoclonal M. pneumoniae antibody (clone 
M2110182, diluted 1:300) from Fitzgerald Industries 
International Inc, Concord MA, USA, C. pneumoniae 
antibody (clone RR-402, anti-protein from the outer 
membrane; non diluted) from Dako, Carpinteria, CA, 
USA, and anti-Human C5b-9-Terminal Complement 
Complex (rabbit polyclonal antibody; diluted 1:75) from 
Calbiochem-Novabiochem Corporation, San Diego, CA, 
USA). The detection was performed with anti-rabbit IgG 
(whole molecule) gold conjugate, 10 nm (1:20) from Sig-
ma Immunochemicals, Saint Louis, MO, USA.
Morphometric analysis - Five photos at 5.500X 
original magnification were used for morphometry. 
We counted the mean numbers of dots (colloidal gold 
particles of 10nm)/ photo, which correspond to an 
area of 23 µm2. We also counted two types of rounded 
structures enclosed by double membranes. These were 
not clearly stained, suggestive of archaeal bodies. One 
had mild electron dense lipidic (EDL) content and 
the other had an apparently clear empty content. We 
named these structures respectively: EDL and electron 
lucent content (ELC) bodies.
The sections were observed by electron transmission 
microscope Philips EM-301 (Eindhoven, Holland).
PCR technique for detection of Archaea and T. cruzi 
DNA - Five paraffin myocardial fragment blocks from pa-
tients with CC were submitted to the PCR technique for 
detection of archaeal and T. cruzi DNA. DNA from the 
fragments was obtained using the PureLink Viral RNA/
DNA Mini Kit (Invitrogen) following the manufacturer’s 
instructions. Five paraffin myocardial fragment blocks 
from patients with CC and three normal adult myocar-
dium samples was submitted to the PCR technique for 
detection of archaeal and T. cruzi DNA. For the isolation 
and purification of genomic DNA we used the PureLink 
Viral RNA/DNA Mini Kit (Invitrogen) following the 
manufacturer’s instructions. Archaeal DNA amplifica-
tion was carried out in 25 µL of reaction mixture un-
der the following conditions: 0.2 mM deoxynucleoside 
triphosphates, 2.5 mM MgCl2, 2.5 U of Platinum Taq 
DNA Polymerase (Invitrogen), 50 pmol of each primer, 1x 
PCR buffer and 100 ng of DNA, using universal archaeal 
primers 1100F (5’ -AGTCAGGTAACGAGCGAG-3’) and 
1400R (5’ -GTGCAAGGAGCAGGGAC-3’) (Kudo et al. 
1997). PCR was performed in a BioRad DNA Engine 
thermocycler using the following program: denaturation 
of DNA at 94°C for 3 min, followed by 35 cycles at 94°C 
for 1 min, 54°C for 1.5 min and 72°C for 1 min, with 10 
min at 72°C for extension at the end. Genomic DNA of 
Halobacterium salinarum INCQS A2 (DZMZ 668) (50 
ng) was used as a positive control. It was kindly provided 
by Prof. Maysa Mandetta Clementino from the Bacteria 
and Archaea Reference Laboratory of the National Insti-
tute of Quality Control in Health, Fiocruz, Rio de Janeiro, 
Brazil. A negative control without DNA was included and 
the PCR reactions were repeated three times to confirm 
the reproducibility of the amplification.
T. cruzi DNA amplifications were carried out with 25 
µL of reaction mixture under the following conditions: 
100 ng of DNA, 50 pmol each primer S34F (5’ -TAT-
ATTACACCAACCCCAATCGAACC-3’) and S67R (5´ 
- TGGTTTTGGGAGGGGSSKTCAAMTTT-3’) (Oli-
vares-Villagómez et al. 1998) 0.2 mM of each deoxynu-
cleoside triphosphate, 1x PCR buffer (pH 9.0), 2,5mM 
MgCl2 and 2 U of Platinum Taq DNA Polymerase (In-
vitrogen). Reactions were run in a BioRad DNA Engine 
thermocycler using the following program: denatu- 
ration of DNA at 94°C for 6 min, followed by 45 cycles 
at 94°C for 40 sec, 57°C for 1 min and 72°C for 45 sec, 
with 10 min at 72°C for extension. As a positive con-
trol, we used genomic DNA from T. cruzi. The mixture 
was run on a 1% electrophoresis agarose gel in 1x TAE 
buffer (40 mM Tris base, 20 mM sodium acetate, 1.0 
mM EDTA, pH 8.0) with a 100-bp DNA ladder (Invi- 
trogen Carlsbad, CA, USA). The gels were stained with 
ethidium bromide (0.5 mg/mL) to visualize the ampli-
fied PCR products under UV illumination.
Statistical analysis - The comparison of DNA quan-
tities and archaeal-like bodies between the two clini-
cal groups was performed using the Student t-test. The 
Pearson correlation test was used to determine the rela-
tionships between different microbe DNAs or antigens 
and complement.
RESULTS
All endomyocardial biopsies were positive for MP-
DNA and CP-DNA by light microscopy examination. 
The mean percent areas detected by ISH in the two 
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groups of patients are shown in Table I. MP-DNA and 
CP-DNA were significantly higher in the IF group than 
in the CC group (p < 0.001). There was a significant pos-
itive correlation between MP-DNA and CP-DNA values 
in the CC group of patients (r = 0.64; p = 0.005) but not 
in the IF group of patients (r = -0.28; p = 0.547).
Qualitative and quantitative analysis - Endomyocar-
dial biopsies from the IF group revealed myocardial fi-
bres with well preserved morphology, large amounts of 
glycogen-like granules in the sarcoplasm and moderate 
dilatation of T tubules, sarcoplasmic reticulum and inter-
calated discs, which frequently contained membranous 
elements in the lumen. Fibrosis in the interstitium usually 
exhibited mycoplasmal-like forms characterized by only 
one outer membrane with a rounded or cylindrical shape. 
Chlamydial bodies characterized by a double membrane 
and dark homogeneous chromatin were rarely seen in 
myocardial fibres, macrophages or the extracellular ma-
trix (Fig. 1A, B). Many EDL balls were present in the 
myocytes either at the subsarcolemal region or more in-
ternally. These were similar to lysosomes but enclosed by 
a barely visibly double external membrane with a darker 
aspect at the periphery. EDLs were always located near 
mitochondria and glycogen-like granules (Fig. 2A, B).
A second type of round organelle enclosed by a double 
membrane was also present. These had ELC with irregu-
lar thin flat tubules, an irregular folded external mem-
brane and sometimes contained a large, clear periplasmic 
space. These EDL and ELC bodies are compatible with 
archaeal morphology and were sometimes fused to each 
other (Fig. 2A). EDL and ELC bodies presented variable 
diameters ranging from around 0.10-1.5 µm.
In CC cases, the myocardial fibres presented more 
intense alterations represented by mitochondrial crystol-
ysis, a clear matrix and dilated reticulum sarcoplasmic 
organelles frequently presenting irregular membranes 
in their lumens. There were many foci of myocytolysis 
usually associated with ELC bodies and a lack of gly-
cogen granules (Fig. 3A, B). There was a severe fibrosis 
in the interstitium, with mycoplasmal forms among the 
collagen fibres. There were many forms of ELC among 
the mononuclear inflammatory cells and in the myocar-
dial fibres. These were associated with mycoplasmal 
forms and round dark structures that may have been 
derived from C. pneumoniae elements (Fig. 3C, D). 
ELC structures were sometimes very large (Fig. 4A, B). 
Glycogen-like granules were usually absent.
Immunogold electron microscopy counting - Immu-
noelectron microscopy demonstrated that the monoclo-
nal antibodies anti M. pneumoniae and C. pneumoniae 
stained surface antigens and free nanolipidic particles 
suggestive of lipoprotein or lipopolysaccharide from 
these bacteria, as had been shown in a previous study 
(Higuchi et al. 2006c). All chagasic EMBs presented high 
amounts of M. pneumoniae and C. pneumoniae as extra-
cellular antigens, as well as in the extracellular matrix 
and myocardial fibres. M. pneumoniae and C. pneumo-
niae were apparently associated with lipid nanovesicles.
Table II shows the mean numbers and standard devi-
ation of gold particles/100 µm2 detected by immunoelec-
tron microscopy and the number of  EDL and ELC bod-
ies detected by transmission electron microscopy in both 
the IF group and the CC group. The unicaudal Student 
t test showed lower levels of C. pneumoniae and higher 
levels of C5b-9, as well as non-significantly lower lev-
els of M. pneumoniae and EDL values, in the CC group 
than in the IF group. ELC values were higher in the CC 
group, without statistical significance. The lack of statis-
tical significance may be linked to the small number of 
samples analyzed.
Table III shows the correlations between the vari-
ables in Table II. The CC group had higher R correlation 
values than the IF group, with significance only between 
C5b-9 and C. pneumoniae antigens (r = -0.96, p = 0.04) 
and an almost significant negative correlation between 
EDL and ELC values (r = -0.97; p = 0.06).
PCR technique for detection of archaeal and T. cruzi 
DNA - All five of the CC paraffin myocardial fragment 
blocks yielded a 300-bp fragment, including the H. sali-
narum reference strain, after PCR with the universal 
archaeal primers (Fig. 5). The same samples described 
above yielded a 122-bp fragment using T. cruzi specific 
primers (Olivares-Villagómez et al. 1998).
DISCUSSION
The exact mechanism for the development of chronic 
dilated cardiopathy in some individuals infected with T. 
cruzi is a still matter of debate. Our results provide evi-
dence that association of mycoplasmal, chlamydial and/or 
archaeal elements might be related to this phenomenon.
Optical, electron and immunoelectron microscopy 
showed that high levels of DNA from C. pneumoniae 
and M. pneumoniae and the presence of archaeal-like 
bodies of the EDL type were associated with IF. Since 
these values did not correlate with each other and be-
cause the morphology was of isolated forms, we con-
clude that these microbes are not closely associated 
with IF. Alternatively, fusion of ELC archaeal-like 
bodies with the microbes described in the IF group 
was present in the CC group. An intimal interaction 
is suggested by the following: (i) the high correlation 
between CP-DNA and MP-DNA, which correlated 
negatively with ELC values; (ii) the negative correla-
tion between the numbers of ELC with the numbers 
of EDL and (iii) the positive correlation between ELC 
and C5b-9 values.
The five samples submitted to PCR analysis yielded 
fragments compatible with the specific primers. Since 
we did not have enough material to perform PCR in the 
IF cases, we could not compare this item. Further studies 
are needed, including a better characterization of EDL 
and ELC organelles to determine if they present differ-
ent archaeal genome sequences.
Mycoplasma can either grow symbiotically with eu-
karyotic cells without producing profound cytotoxicity 
or it may provoke a marked host response, acting as a 
super antigen by triggering apoptosis of the CD4+ T 
cells (Lo 1992). Mycoplasma has the ability to evade the 
immune system by antigenic variation and resistance to 
complement lysis (Simmons et al. 2004). However, My-
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coplasma may increase the virulence of other microbes 
(Dessi et al. 2005) and may induce pro-inflammatory 
cytokines such as TNFα, IL-6 and TGFβ (Blanchard 
& Bebear 2002, Yang et al. 2004), which are related to 
heart failure (Sharma et al. 2001, Sugamori et al. 2002). 
Chlamydia is also a frequent symbiont of microbes and 
has the ability to prevent apoptosis of the host cell (Fan 
et al. 1998, Sharma & Rudel 2009). Archaea have anti-
oxidative enzymes, such as superoxidismutase, that pro-
mote microbe survival (Cannio et al. 2000) and pepti-
dases and proteasomes that contribute to degradation of 
aggregation-prone proteins and reduce cellular toxicity 
in mammalian cells (Yamada et al. 2006).
The presence of M32 family MCP, which is known 
to be specific to the Archaea and bacteria kingdoms, 
was described in T. cruzi (Niemirowicz et al. 2007). The 
authors suggest that the protozoan has acquired these 
genes by horizontal transfer of an ancestral archaea 
gene. Consistent with this hypothesis, the T. cruzi MCP 
has high biochemical similarity with Archaeon P. fu-
riosus (Pfu). Pfu M32 MCP seems to be involved in the 
utilization of peptides and proteins for the metabolism 
of the organism (Schul et al. 2003).
Sequences of both the 20S proteasomes and hsIV 
were found in T. cruzi, suggesting the presence of en-
TABLE I
Percentage of area positive for Mycoplasma pneumoniae DNA 
(MP-DNA) and Chlamydia pneumoniae DNA (CP-DNA) in 
endomyocardial biopsies from chagasic patients in indetermi-
nate (IF) or chronic cardiac (CC) forms by in situ hybridization 
technique in light microscopy and Pearson correlation test
Group % MP-DNA
mean (± SD)
% CP-DNA
mean (± SD)
Correlation
coefficient
MP vs. CP
IF (n = 7) 8.75 (4.00) 9.66 (4.22) - 0.28 (p = 0.547)
CC (n = 17) 2.65 (1.64) 3.43 (2.65) 0.64 (p = 0.005)
p (t test) 0.001 < 0.001
Fig. 1: ultrastructural aspects of an indeterminate asymptomatic form 
endomyocardial biopsy. A: a group of microbes, suggestive of myco-
plasmal and chlamydial bodies, well individualized each other, amidst 
the fibrosis; B: intercalated disc (ID) with well preserved desmosomes 
(thin arrows) and dilated fascia adherens containing a membranous 
element in the lumen (white arrow). CP: Chlamydia pneumoniae; FA: 
Fascia Adherens MP: Mycoplasma pneumoniae.
Fig. 3: ultrastructural aspects of a heart failure group endomyocar-
dial biopsy. A: severe myocytolysis of the myocardial fiber. The white 
arrow indicates an electron lucent content (ELC) structure formed 
by two compartments, which is in close view in B. The black arrow 
indicates a mycoplasmal body; C: close view; D: a myocardial fiber 
with myocytolysis (asterisk), with some apparently symbiotic forms 
of mycoplasma, ELC and Chlamydia pneumoniae.
Fig. 2: ultrastructural aspects of an indeterminate asymptomatic form 
endomyocardial biopsy. A: a panoramic view of a myocardial fiber 
contain mainly many electron dense lipidic (EDL) bodies (thin ar-
rows) and few electron lucent content bodies, one fused with one EDL 
body (empty arrow); B: higher magnification of an EDL body divided 
in two lobes (arrow), exhibiting doubled external membrane, electron 
dense lipidic internal material darker at the periphery.
dosymbionts, for example, an α-proteobacterial pro-
genitor of mitochondria. Alternatively, horizontal gene 
transfer by temporal association with bacteria within the 
intestines of insects could account for the presence of 
these sequences (Gille et al. 2003). T. cruzi undergoes 
profound morphological changes using proteins from the 
host cell during its life cycle in the myocardial fibres. 
An essential role for proteasomes in the degradation of 
cytoplasmic proteins has been demonstrated (Gonzalez 
et al. 1996, De Diego et al. 2001).
T. cruzi presents lysosome-related organelles or re- 
servosomes, which contain many enzymes, including 
carboxypeptidases (Sant’Anna et al. 2008). The lyso-
some-related organelle or reservosome’s morphology is 
similar to the EDL bodies described in the present 
study, mainly in IF EMBs. These bodies have a barely 
visible double membrane, and some types are apparently 
divided by the presence of two lobes. These findings led 
us to propose that these EDL bodies could be archaea.
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In CC EMBs we observed ELC archaeal-like bodies. 
Their morphology is similar to the morphology of those 
present in the myxoid matrix of vulnerable atheroma 
plaques that are associated with vessel dilatation and 
adventitial inflammation in correlation with C. pneumo-
niae and M. pneumoniae elements (Higuchi et al. 2003b, 
2006b). The ELCs were in the interstitium among the 
chronic inflammatory infiltrate, sometimes with a huge 
periplasmic space containing nanoarchaeal-like bodies. 
This morphology is similar to that of Ignicoccus hospi-
talis (Junglas et al. 2008).
The unique ether glycerolipids of Archaea can form 
vesicles (archaeosomes or liposomes from Archaea) with 
strong adjuvant activity for MHC class II presentation. 
The archaeosomes are superior adjuvants that induce a 
long-term CD8+ cytotoxic T cell response to entrapped 
soluble protein in the absence of help from CD4+ T cells 
(Krishnan et al. 2000). It has been shown that chronic 
chagasic active myocarditis in CC patients presents in-
flammatory infiltrate composed mainly of CD8+ T cells 
with increased numbers in the presence of T. cruzi an-
tigens, and a lack of CD4+ T cells (Higuchi et al. 1993b, 
1997, Reis et al. 1997). We argue that T. cruzi antigens 
in archaeosomes may not be the cause of this increased 
inflammatory infiltrate.
Based on the literature, we may speculate that symbi-
otic forms involving Mycoplasma, Chlamydia and ELC 
organelles in the human chronic infection by T. cruzi 
causes increased immune activation by complement de-
position and lymphocyte activation leading to the devel-
opment of myocarditis. However, the presence of non-at-
tached mycoplasmal, chlamydial and EDL archaeal-like 
bodies leads to reduced myocardial inflammation.
The current view of microbiologists is that prokary-
otes’ predominant state of being is inside microbial com-
munities. Direct interaction between archaea has been 
proved to mediate exchange of chromosomal DNA, me-
tabolites or substrates from the cytoplasm of one cell 
to another (Junglas et al. 2008). The association of dif-
ferent species of microorganisms leads to the develop-
ment of more resistant and productive new associated 
forms (Hansen et al. 2007). Also, the presence of one 
pathogen may inhibit the growth of others. Mycoplasma 
inhibited the growth of Chlamydia in in vitro studies 
TABLE II
Mean numbers and standard deviation of gold particles/100µm2 
Mycoplasma pneumoniae (MP), Chlamydia pneumoniae (CP) 
and membrane attack complex (MAC) antigens in immuno-
eletron microscopy and archaeal-like bodies/100µm2 in elec-
tron microscopy, in indeterminate (IF) and chronic cardiac 
(CC) forms
Groups MP CP MAC EDL ELC
IF (n = 5) 48 ± 22 48 ± 17 56 ± 13 0.13 ± 0.04 0.04 ± 0.04
CC (n = 4) 39 ± 17 17 ± 8.7 100 ± 43 0.09 ± 0.09 0.06 ± 0.04
p (t test) 0.30 0.005 0.04 0.19 0.31
EDL: electron dense lipidic bodies; ELC: electron lucent con-
tent bodies.
TABLE III
Correlation coefficient and p value between mean numbers 
of Mycoplasma pneumoniae (MP), Chlamydia pneumoniae 
(CP) and membrane attack complex (MAC) antigens at the 
immunoelectron microscopy and electron dense lipidic (EDL) 
bodies and electron lucent content (ELC) bodies at the elec-
tron microscopy
CP MAC EDL ELC
MP IF - 0.51 (0.38) 0.33 (0.59) - 0.21 (0.73) - 0.04 (0.95)
CC - 0.71 (0.29) - 0.81 (0.19) 0.77 (0.23) - 0.85 (0.14)
CP IF 0.007 (0.99) - 0.31 (0.61) - 0.34 (0.57)
CC - 0.96 (0.04) 0.34 (0.66) - 0.64 (0.36)
MAC IF 0.37 (0.53) - 0.60 (0.28)
CC - 0.33 (0.67) 0.60 (0.40)
EDL IF - 0.53 (0.34)
CC - 0.97 (06)
Fig. 4: details of a foci of inflammatory infiltrate in a chronic cardiac 
case. A: among the mononuclear inflammatory cells, there are some 
suggestive of Archaeal large bodies characterized by rounded struc-
tures surrounded by two membranes, large periplasmic space contain-
ing amorphous and granules content and an internal vacuole (small ar-
rows); B: a close view of the periplasmic space with many clear double 
membrane round structures suggestive of nanoarchaea (large arrow).
Fig. 5: PCR amplifications of Archaea (primers 1100/1400) in tissues 
samples of chagasic patients. Lane M: molecular size marker (100-bp 
DNA ladder); Lane 1: negative control with no added template DNA; 
Lanes 2-6: tissue samples of chagasic patients; Lane 7: positive control 
(Halobacterium salinarum).
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(Van Nerom et al. 2000). Escherichia coli inhibited the 
growth of T. cruzi (Cortez et al. 2006). High ratios of M. 
pneumoniae/C. pneumoniae were related to an increased 
amount of growth factors and fibrosis in atheroma 
plaques (Higuchi et al. 2006a).
Limitations and clinical implications - The present 
work is a retrospective study with a small number of 
cases that cannot result in definite conclusions. However, 
our results may suggest a new frontier of investigation in 
Chagas cardiopathy pathogenesis, specifically the symbi-
otic interaction among prokaryotes and a trypanosome.
In conclusion, different amounts of Mycoplasma, 
Chlamydia and archaeal elements may be implicated in 
complement activation and may have a role in Chagas 
disease outcome. IF was associated with isolated forms 
of these microbes and with the EDL type of archaeal-
like bodies. CC was associated with fusion of these 
microbes and ELC archaeal-like bodies in association 
with increased myocardial complement deposition. 
These findings open a new direction for pathogenetic 
studies and the possibility of new prognostic biomark-
ers in Chagas disease.
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